Fig. 9From: Biocompatible Nanoparticles as a Platform for Enhancing Antitumor Efficacy of Cisplatin–Tetradrine CombinationMale ICR mice bearing a subcutaneous H22 tumor at the left axillary (arrows). CT, PET and fused PET/CT images are arranged in the figure from left to right. Tumor metabolic rate in free CDDP plus Tet group (blue arrow) was significantly higher than NPs group (yellow arrow)Back to article page